Introduction
============

Primary malignant tumors of the trachea are very rare with the incidence of less than two *per* million people *per* year and they account for less than one percent of all malignant tumors ([@r1], [@r2]). Eighty percent of all tracheal tumors are malignant ([@r2]). Most common are squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) ([@r1], [@r2]). While SCC is usually located in the distal part, ACC is usually located in the proximal part of the trachea ([@r1]). ACC grows slowly and clinical course is long. It metastasizes to distant sites and can recur after a long interval. Treatment of choice is surgical resection. If the tumor is too large for resection or unresectable due to invasion of adjacent organs, radiotherapy is used ([@r1]-[@r7]). We present a case of a 43-year-old male patient, member of the cruise ship staff. He was hospitalized for severe stridor and dyspnea and diagnosed with distal tracheal tumor that was not SCC but ACC. This is a rare presentation of this type of tumor and any report of ACC is valuable for data accumulation. This case is specific for unusual localization in distal trachea.

Case Report
===========

A 43-year-old patient with dyspnea and severe stridor was hospitalized in a general hospital. Computed tomography (CT) scan of the chest revealed distal tracheal tumor almost obstructing complete lumen of distal trachea ([Figs. 1 and 2](#f1){ref-type="fig"}[](#f2){ref-type="fig"}). The patient was intubated and transferred to our hospital. After bronchoscopic assessment, an intervention was performed. About half of the tumor volume was removed by bronchoscopic excision. Tracheal lumen was re-established by photocoagulation and additional dilatation. Precisely determined localization after bronchoscopic intervention revealed a tumor one centimeter proximally to the carina infiltrating anterior wall of the trachea by about three centimeters in length. Histopathology confirmed primary ACC. Three days after tracheal recanalization, right thoracotomy, resection of the affected part of the trachea and mediastinal lymphadenectomy was performed. The supracarinal segment of the trachea was resected and end-to-end anastomosis created. Histopathology revealed submucosal spread of the tumor with a positive margin. Anastomosis healed well and follow up bronchoscopy status was satisfactory ([Fig. 3](#f3){ref-type="fig"}). The patient had no respiratory problems. He was discharged on postoperative day 8. Adjuvant radiation therapy was recommended.

![Chest CT scan showing tumor in distal trachea with barely patent lumen (arrow) -- axial view.](acc-58-777-f1){#f1}

![Chest CT scan showing tumor in distal trachea with barely patent lumen (arrow) -- coronal view.](acc-58-777-f2){#f2}

![Bronchoscopy showing precarinal anastomosis with both main bronchi.](acc-58-777-f3){#f3}

Discussion
==========

Primary ACC, previously also called cylindroma, is a rare tumor ([@r1], [@r2]). Only two cases of tracheal tumors *per* million people *per* year are recorded, with ACC accounting for about ten percent of these ([@r8]). Both sexes are affected equally in the fifth decade of life. It is not a smoking related condition ([@r9]). Usual symptoms are cough, wheezing and dyspnea, and patients are often treated for asthma before reaching an accurate diagnosis ([@r2], [@r3]). This tumor does not have a capsule and spreads directly by submucosal or perineural invasion. More than half of these patients have metastatic disease by hematogenous spread ([@r2]). Lung is the most common site of metastases. Other affected organs are brain, liver, kidney, skin and bone ([@r7], [@r10]). Typical presentation is intraluminal mass on chest CT scan, which infiltrates tracheal wall and obstructs airway.

Treatment includes surgery, radiation therapy, or a combination of both. If possible, resection with end-to-end anastomosis should be performed. It is the best option for localized lesion. The nature of spread is the most important reason for incomplete resection ([@r11]). The rates of reported complete resections are around fifty percent ([@r1], [@r8]). In this case, adjuvant radiation therapy is mandatory ([@r1], [@r5], [@r9]). There are controversies about adjuvant radiation therapy in clear margin cases and local *versus* systemic radiation therapy ([@r1], [@r4], [@r9]). In our case, we recommended adjuvant radiation therapy because there was positive margin on histopathology.

Conclusion
==========

Adenoid cystic carcinoma is an extremely rare condition with less than one case *per* year in our country. The symptoms are somewhat confusing and can lead to misdiagnosing and wrong treatment. Once the accurate diagnosis is made, treatment options are narrow and include surgery alone, radiation therapy, or a combination of both. Survival is almost the same for patients treated by surgery only and those treated by adjuvant radiation therapy but data on this are not satisfactory. The reason for that is the small number of cases and inadequate follow up. However, it is clear that all patients with positive resection margin need adjuvant radiation therapy. In these cases, oncologic approach is restricted by anatomic limitations and poses a therapeutic challenge. Individual approach to every patient is needed.
